MSH|^~\&|LAB|CGH|||202003161417||ORU^R01|4186340|D|2.3|||AL|NE
PID|1||CG00002205|AB6667|LABTEST^CGH^SPACE||19650101|F||||||||||CG000007/19|
OBR|1|40483^LAB|00030514^1603:CA00001R^LAB^160320:CA1^40483|521.1420^T4FREE^T4 (Thyroxine) Free^^^14920-3||202003161357|202003161345|||||||202003161357||||||||||LAB|F||||
OBX|1|ST|521.1430^T4FREE R^T4 (Thyroxine) Free^^14920-3^14920-3|1|6^^Y|pmol/L|8-15|L||A^S|F|||202003161417
NTE|1||Method:Beckman Access/DxI
OBR|2|40483^LAB|00030514^1603:CA00001R^LAB^160320:CA1^40483|521.1510^T3FREEREQ^T3 Free Request^^X10346^XXX-1773||202003161357|202003161345|||||||202003161357||||||||||LAB|I||||
OBR|3|40483^LAB|00030514^1603:CA00001R^LAB^160320:CA1^40483|521.1730^TSH^Thyroid Stimulating Hormone^^^3016-3||202003161357|202003161345|||||||202003161357||||||||||LAB|F||||
OBX|1|ST|521.1740^TSH R^Thyroid Stimulating Hormone^^3016-3^3016-3|1|10.20^^Y|mU/L|0.30-5.50|H||A^S|F|||202003161417
NTE|1||During Pregnancy:
NTE|2||T1: 0.10 - 3.50 mU/L
NTE|3||T2: 0.30 - 3.50 mU/L
NTE|4||T3: 0.45 - 4.00 mU/L
NTE|5||
NTE|6||Reference intervals are based on treatment thresholds
NTE|7||included in the 2017 American Thyroid Association Guidelines